Mainz Biomed

What Mainz Biomed does

Mainz Biomed N.V., founded in 2013 and incorporated in the Netherlands, was originally a molecular genetics diagnostics company that developed and marketed ColoAlert, a non-invasive DNA-based colorectal cancer screening test in Europe, and pursued FDA registration for U.S. expansion alongside an early-stage PancAlert pancreatic cancer screening program. In February-March 2026, following a $6.0 million private placement with investor David Lazar, the company executed a complete strategic pivot and rebrand to Quantum Cyber N.V. (NASDAQ: QUCY), with Robert Liscouski — a homeland security and quantum computing executive — appointed Chairman. The current business is an autonomous defense and quantum-accelerated technology company assembling a System-of-Systems platform across air, land, and sea domains.

The company's product portfolio now centers on five disclosed offerings: (1) an Autonomous Drone Platform with multi-mission UAVs and 25+ km range, (2) a Perimeter Defense & Counter-UAS system with tethered sensor drones and kinetic interceptors operating in RF-silent, GPS-denied environments, (3) Autonomous Demining Systems using acoustic, magnetic, and pressure influence-neutralization, (4) Quantum Antenna Technology (in development) for multi-band encrypted drone communications, and (5) Quantum Station, a battlefield command-and-control platform unifying all assets with cyber-secure Linux OS, AES-256 encryption, ELRS 900 MHz communications, and open-architecture drone compatibility. The 'quantum advantage' is asserted through QAOA-based swarm path planning and quantum reinforcement learning architectures, though no technical validation, patents, or independent benchmarks are disclosed.

The business model is B2G/B2B defense sales targeting U.S. and allied militaries, with no publicly disclosed pricing. The company has signaled U.S. federal alignment via National Quantum Initiative compliance and Capitol Hill engagements, while the residual ColoAlert diagnostic business is being explored for divestiture and the German subsidiary is being wound down. Distribution is direct and channel-based (notably the OncoVanguard8 MOU for South American ColoAlert distribution pre-pivot), and the operating footprint is centered on Berkeley, California and West Palm Beach, Florida. The market capitalization stands at approximately $8.66 million as of March 2026, down 85% year-over-year, with a current ratio of 0.52 indicating short-term obligations exceed liquid assets.

Name

Mainz Biomed

Legal name

Quantum Cyber N.V.

Website

https://mainzbiomed.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Quantum Cyber N.V. (NASDAQ: QUCY, formerly Mainz Biomed) is an autonomous defense technology company building a quantum-accelerated System-of-Systems platform for drone warfare, counter-UAS, and demining, serving U.S. and allied defense and government buyers.

Ownership category

akta.pro rank

Product category

Autonomous Defense Systems

NAICS

Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing (334511), Security Systems Services (56162), Computer Systems Design Services (541512)

SIC

Search, Detection, Navagation, Guidance, Aeronautical Sys (3812), Ordnance & Accessories, (No Vehicles/Guided Missiles) (3480)

akta.pro primary industry

Autonomous Defense Systems (AI/ML, Swarming, MUM-T) (IMABAOAI)

akta.pro secondary industries

Managed Quantum Services & Enterprise Support (HDAGAIAI), Multi-Provider Quantum Aggregators & Marketplaces (HDAGAIAC)

Keywords

• Autonomous defense systems
• Counter-drone technology
• Quantum antenna systems
• Battlefield command systems
• Autonomous demining systems

Headquarters

HQ city

West Palm Beach

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. ColoAlert Commercial Sales: Commercialization of ColoAlert, a non-invasive colorectal cancer screening test marketed in Europe, with plans for US expansion through FDA registration.
2. Pancreatic Cancer Test Development: Development of PancAlert pancreatic cancer screening test for US market with public funding support from ISB covering up to 50% of project costs.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Mainz Biomed (now Quantum Cyber N.V., NASDAQ: QUCY) develops and sells autonomous defense hardware and integrated systems for drone warfare, counter-UAS operations, and multi-domain autonomous warfare. The portfolio includes multi-mission UAVs, dual-tier perimeter defense and counter-UAS systems, autonomous demining systems, quantum antenna technology, and the Quantum Station battlefield command-and-control platform. The company is also winding down its legacy molecular diagnostics business (ColoAlert DNA-based colorectal cancer screening test) as part of a strategic pivot to defense technology.

Product overview

Mainz Biomed (now operating as Quantum Cyber N.V., NASDAQ: QUCY) has undergone a strategic pivot from molecular cancer diagnostics to become an autonomous defense technology company. The company is assembling a diversified portfolio of autonomous defense technologies under a System-of-Systems architecture, including an Autonomous Drone Platform, Perimeter Defense & Counter-UAS system, Autonomous Demining Systems, and Quantum Antenna Technology. The unified command layer is provided by Quantum Station, a battlefield operating system for multi-domain autonomous drone operations. The company applies quantum computing principles including QAOA, quantum reinforcement learning, and quantum-accelerated antenna systems to enable large-scale autonomous swarm deployment.

Differentiator

Problem solved

Functional benefit

Brands

• ColoAlert: DNA-based non-invasive colorectal cancer screening test
• PancAlert
• Quantum Station

Products and services

• Quantum Station Purpose-built battlefield command-and-control platform serving as the central nervous system for multi-domain autonomous drone operations, unifying all autonomous systems across air, land, and sea. Designed for defense and military customers requiring secure tactical command.
• Autonomous Drone Platform Multi-mission UAV systems for surveillance, interdiction, and payload delivery with range exceeding 25 kilometers, fully autonomous takeoff, navigation, and landing capabilities, and encrypted multi-platform mission configurations. For defense and military customers.
• Perimeter Defense & Counter-UAS Dual-tier autonomous perimeter shield with outer ring of tethered sensor drones featuring passive acoustic and MWIR thermal detection, and inner ring of kinetic interceptors with GPS-free terminal guidance, operating in RF-silent and GPS-denied environments with human-on-the-loop architecture. For defense bases, critical infrastructure, and military installations.
• Autonomous Demining Systems Acoustic, magnetic, and pressure influence-neutralization technology for remote mine detection and clearance, designed for active conflict theater deployment and post-conflict humanitarian demining programs. For defense agencies and humanitarian organizations.
• ColoAlert Non-invasive DNA-based colorectal cancer screening test for early detection, marketed in Europe with plans for US expansion via FDA registration. Being divested as the company pivots to defense technology. Targeted at gastroenterology practices and healthcare systems.

Quantifiable outcome

• 100% sensitivity and 95% specificity in pancreatic cancer detection feasibility study

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• OncoVanguard8coreChannel Partner/ Reseller/ Distributor · 18 November 2025Memorandum of Understanding signed to introduce ColoAlert DNA-based colorectal cancer screening test to South America, starting with Peru. Targets markets with high colorectal cancer incidence.
• Crown BiosciencecoreStrategic or Co-development Partner · 25 June 2025Collaboration with Crown Bioscience to evaluate biomarkers and machine learning algorithms for blood-based pancreatic cancer screening test development. Project is in feasibility stage.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Anduril Industries: Anduril's Lattice OS is the closest analog to Quantum Cyber's Quantum Station — a software command layer unifying autonomous air, ground, and maritime systems for the DoD. Anduril competes head-on in counter-UAS, autonomous drones, and system-of-systems defense platforms.
• Shield AI: Shield AI's Hivemind autonomy software enables autonomous drone swarm operations and has been adopted across DoD programs. Direct overlap with Quantum Cyber's autonomous drone platform and QAOA-based swarm coordination narrative.
• DroneShield: DroneShield specializes in counter-UAS detection and defeat systems — directly overlapping with Quantum Cyber's Perimeter Defense & Counter-UAS product line. Listed on the ASX with established DoD and critical-infrastructure customer base.
• Epirus: Epirus builds counter-electronics and counter-UAS directed-energy systems with significant DoD contracts. Competes in the same counter-drone procurement lane as Quantum Cyber's Perimeter Defense offering.
• Fortem Technologies: Fortem builds counter-UAS solutions including DroneHunter interceptor drones — directly comparable to Quantum Cyber's inner-ring kinetic interceptor approach with GPS-free terminal guidance.

Broad incumbents

• AeroVironment: AeroVironment is an established tactical UAV manufacturer with deep DoD programs of record (Switchblade, Puma). Competes with Quantum Cyber's Autonomous Drone Platform but at a vastly larger scale and with proven battlefield deployments.
• Kratos Defense & Security Solutions: Kratos produces target drones, tactical UAS, and unmanned combat systems with substantial DoD revenue. Overlaps with Quantum Cyber's drone warfare and autonomous systems focus area.
• Palantir Technologies: Palantir's Gotham and AIP platforms provide data integration and command-and-control layers for DoD customers. Competes indirectly with Quantum Station as a platform/OS layer in defense applications.
• L3Harris Technologies: L3Harris is a diversified defense prime with significant counter-UAS and autonomous systems portfolios across multiple service branches. Sets the procurement baseline Quantum Cyber must displace or partner with to win DoD programs.

Emerging players

• Skydio: Skydio's autonomy platform powers autonomous drones for defense, public safety, and commercial markets — overlapping with Quantum Cyber's autonomous drone platform, though Skydio has not yet built a counter-UAS capability.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/QuantumCyberIR
• LinkedInlinkedin.com/company/quantum-cyber

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds8 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mainz Biomed